Javascript must be enabled to continue!
Mutations dislocate caspase‐12 from the endoplasmatic reticulum to the cytosol
View through CrossRef
Mouse AKR‐2B cells express two forms of caspase‐12: the full‐length form coding for a protein of 47.8 kDa and a new splice variant of 40.2 kDa which is devoid of the CARD domain. In addition, three point mutations were disclosed: I/L‐15, E/D‐46 and P/L‐105. A major portion of the two protein variants was found in the cytosol. Immunofluorescence studies showed an even distribution of caspase‐12 within the cell, indicative for a cytoplasmatic localization. Transfection of AKR‐2B cells with wild‐type caspase‐12 showed a colocalization of this protein with the endoplasmic reticulum (ER). Unlike mouse embryonal fibroblasts (MEF) which contain wild‐type caspase‐12, AKR‐2B cells were largely resistant against treatment with the endoplasmatic reticulum stressing reagents brefeldin and tunicamycin. In AKR‐2B cells, cytoplasmatic caspase‐12 is bound to high molecular weight complexes of >1000 kDa [Cell Death Differ. 9 (2001) 125] and serum depletion leads to cleavage and detachment of caspase‐12 from this high molecular weight complex. Cleavage of caspase‐12 and ‐3 occurred almost simultaneously reaching a maximum 3–5 h after serum deprivation at which time also maximum apoptosis is found. Analysis of caspase‐12 cleavage in vitro in comparison with fragmentation in vivo suggests that during death in AKR‐2B cells induced by starvation, cleavage was brought about by caspase‐3 at positions D24 and D94. Thus, mutated caspase‐12 is differently integrated in signaling pathways of cell death and has lost its function as initiator caspase upon ER‐stress. Instead, it is turned into a substrate of effector caspases. The implication of these findings in the pathological phenotype of ARK‐2B mice is discussed.
Title: Mutations dislocate caspase‐12 from the endoplasmatic reticulum to the cytosol
Description:
Mouse AKR‐2B cells express two forms of caspase‐12: the full‐length form coding for a protein of 47.
8 kDa and a new splice variant of 40.
2 kDa which is devoid of the CARD domain.
In addition, three point mutations were disclosed: I/L‐15, E/D‐46 and P/L‐105.
A major portion of the two protein variants was found in the cytosol.
Immunofluorescence studies showed an even distribution of caspase‐12 within the cell, indicative for a cytoplasmatic localization.
Transfection of AKR‐2B cells with wild‐type caspase‐12 showed a colocalization of this protein with the endoplasmic reticulum (ER).
Unlike mouse embryonal fibroblasts (MEF) which contain wild‐type caspase‐12, AKR‐2B cells were largely resistant against treatment with the endoplasmatic reticulum stressing reagents brefeldin and tunicamycin.
In AKR‐2B cells, cytoplasmatic caspase‐12 is bound to high molecular weight complexes of >1000 kDa [Cell Death Differ.
9 (2001) 125] and serum depletion leads to cleavage and detachment of caspase‐12 from this high molecular weight complex.
Cleavage of caspase‐12 and ‐3 occurred almost simultaneously reaching a maximum 3–5 h after serum deprivation at which time also maximum apoptosis is found.
Analysis of caspase‐12 cleavage in vitro in comparison with fragmentation in vivo suggests that during death in AKR‐2B cells induced by starvation, cleavage was brought about by caspase‐3 at positions D24 and D94.
Thus, mutated caspase‐12 is differently integrated in signaling pathways of cell death and has lost its function as initiator caspase upon ER‐stress.
Instead, it is turned into a substrate of effector caspases.
The implication of these findings in the pathological phenotype of ARK‐2B mice is discussed.
Related Results
Abstract 2940: Statin induced apoptosis in human melanoma cells is prevented by inhibition of caspase 2 and translational activity.
Abstract 2940: Statin induced apoptosis in human melanoma cells is prevented by inhibition of caspase 2 and translational activity.
Abstract
Background: Statins may trigger apoptosis in tumour cells in vitro and, particularly, melanoma cells are susceptible to statin induced apoptosis. Lipophilic...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Abstract
Introduction. Ultra-deep next generation sequencing (NGS) allows sensitive detection of mutations and estimation of their clonal abundance in tumor cell pop...
Distinct Profile of FLT3 Mutations in Brazil.
Distinct Profile of FLT3 Mutations in Brazil.
Abstract
Mutations in the tyrosine kinase receptor FLT3 are the most common molecular abnormality in acute myeloid leukemia (AML) being detected in about 30% of AML ...
Nitric Oxide Synthase - Nitric Oxide Involvement in the Human Neutrophil Free Radical Generation: Role of iNOS and Rac2 Interaction
Nitric Oxide Synthase - Nitric Oxide Involvement in the Human Neutrophil Free Radical Generation: Role of iNOS and Rac2 Interaction
Abstract
Abstract 1036
Aims:
Previous reports from this lab demonstrated importance of nitric oxide (NO) in augme...
Increased expression of caspase 1 during active phase of connective tissue disease
Increased expression of caspase 1 during active phase of connective tissue disease
Key factors of pyroptosis play an important role in the inflammatory response to connective tissue disease (CTD). However, information on active and stable stages of CTD is scarce....
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract
Abstract 1606
Introduction:
Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...
Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma
Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma
Introduction: The activated B-cell-like (ABC) molecular subgroup of diffuse large B-cell lymphoma (DLBCL) is characterized by activation of NF-κB signaling and increased mortality....

